Bendazac
Bendazac, also known as Bendazolic acid, is a small molecule investigated for its potential anticataract properties. Research suggests its mechanism may involve inhibiting lens protein denaturation, supporting its study in both in vitro protein stability assays and in vivo cataract models.
Product Specifications
CAS Number
20187-55-7
Product Name Alternative
Denaturation, choleretic, Bendazolic acid, Bendazac, cataractogenic, AF-983, AF983, AF 983, antilipidaemic, antinecrotic, Inhibitor, inhibit, inflammatory, protein
Field of Research
Pharmacology & Drug Discovery
Purity
97.06% (May vary between batches)
Solubility
DMSO:60 mg/mL (212.55 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.08 mM)
Smiles
C (N1C=2C (C (OCC (O) =O) =N1) =CC=CC2) C3=CC=CC=C3
Molecular Formula
C16H14N2O3
Molecular Weight
282.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog